As of 2025-07-15, the Relative Valuation of Prometheus Biosciences Inc (RXDX) is (43.77) USD. This relative valuation is based on P/E multiples. With the latest stock price at 199.92 USD, the upside of Prometheus Biosciences Inc based on Relative Valuation is -121.9%.
The range of the Relative Valuation is (42.45) - (59.45) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 13.5x - 18.9x | 13.6x |
| Forward P/E multiples | 13.1x - 21.5x | 14.2x |
| Fair Price | (42.45) - (59.45) | (43.77) |
| Upside | -121.2% - -129.7% | -121.9% |
| Date | P/E |